R. Américaines and I. , Infectious Diseases Society of America (55), p.67

C. Au, Évaluation des pratiques dans le service d'hémato-­?oncologie, p.75

. Enfants-en-neutropénie-fébrile, La durée de la neutropénie et du traitement était plus courte chez les patients traités par caspofungine

B. 1. Blot, F. Nitenberg, G. Levlercq, and B. , Infections graves chez l'immunodéprimé en oncohématologie, EMC-­? Anesthésie-­?Réanimation, vol.9, issue.2, pp.1-25, 2001.

F. Blot, Pronostic des infections en oncohématologie. Prognosis of infections in patients with solid tumors and hematologic malignancies. Reanimation, 2003.

G. Beaucaire, S. Alfandri, and O. Leroy, Prise en charge diagnostique et thérapeutique des infections a Aspergillus SP. et CANDIDA SP. chez les patients immunodéprimé, Med Mal Infect, vol.35, issue.3, pp.121-155, 2004.

T. Walsh, I. Lutsar, and T. Driscoll, Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infec Dis Jour, pp.240-248, 2002.

T. Walsh, P. Adamson, and N. Seibel, Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, 2005.
DOI : 10.1128/AAC.49.11.4536-4545.2005

B. Cazenave, F. Lanternier, and O. Lortholary, Nouveaux antifongiques systémiques ( nex antifungals) La lettre de l'Infectiologue, pp.178-84, 2010.

F. Queiroz-­?telles, E. Berezin, and G. Leverger, Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis, The Pediatric Infectious Disease Journal, vol.27, issue.9, pp.820-826, 2008.
DOI : 10.1097/INF.0b013e31817275e6

B. Reignier, A. M. , and B. Y. , Prise en charge des candidoses et aspergilloses invasives de l'adulte: conférence de consensus commune SFAR, pp.5-13, 2004.

D. Yilmaz, C. Balkan, Y. Ay, M. Akin, B. Karapinar et al., A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections, Mycoses, vol.48, issue.3, pp.234-276, 2011.
DOI : 10.1128/AAC.48.6.2166-2172.2004

K. Marr, M. Boeckh, and R. Carter, Combination Antifungal Therapy for Invasive Aspergillosis, Clinical Infectious Diseases, vol.84, issue.6, pp.797-802, 2004.
DOI : 10.1182/blood.V97.11.3390

E. Merlin, C. Galambrun, and P. Ribaud, Efficacy and safety of caspofungin therapy in children with invasive fungal infections. Pediatr Infec Dis Jour, 2006.

B. Barry, F. Bricaire, and C. Brun-­?buisson, Antimycosqiue à usage systémique. ARS, 2012.